
PT-141, also called bremelanotide, is a cyclic seven-amino-acid melanocortin receptor agonist first identified as an active metabolite of Melanotan II. Research has examined its central action at the MC4 receptor in the brain, which distinguishes it from compounds acting on vascular tissue. Its development history includes blood-pressure increases observed in earlier trials.
$35.00
In stock
For laboratory research use only. Not for human consumption.